Do you provide AMPK/mTOR sensing pathways?

No company has listed this service yet. Add it to your company profile to be the first provider shown here.

Definition

Measuring AMPK and mTOR signalling in skin cells

AMP-activated protein kinase (AMPK) is activated by phosphorylation at threonine 172 when the ratio of AMP to ATP rises. Once active, it phosphorylates acetyl-CoA carboxylase (ACC) and other targets that slow energy-consuming processes and favour energy production. Mechanistic target of rapamycin (mTOR), acting mainly through the mTORC1 complex, has the opposite job. It reads amino acids and growth factors and promotes protein synthesis through targets such as p70 S6 kinase and 4E-BP1. AMPK can inhibit mTORC1, so the two are measured together to see the full balance.

Phospho-protein assays

Keratinocytes or fibroblasts are treated with the ingredient at non-toxic concentrations, then lysed at set time points. The laboratory measures phosphorylated and total protein for each target by Western blot, phospho-specific ELISA or bead-based multiplex assay, and reports the ratio of phosphorylated to total protein.

  • Phospho-AMPK (Thr172) and phospho-ACC
  • Phospho-mTOR and phospho-p70 S6 kinase
  • Phospho-4E-BP1
  • Total protein for each target

AICAR and rapamycin controls across time points

A reference AMPK activator such as AICAR and an mTOR inhibitor such as rapamycin confirm that the model responds as expected. Pathway phosphorylation changes quickly after exposure, so the protocol samples several time points. Viability is checked in parallel on the same treatment plates.

Phospho-to-total ratios and blot images reported

The report includes blot images or assay read-outs, quantified phospho-to-total ratios, concentration-response graphs and statistics. It states which arm of the pathway the ingredient moved and at what concentration.

Applications

Putting AMPK/mTOR pathway data to work

Pathway data gives a named molecular target, which is often the first thing a technical buyer at a brand asks for. An ingredient that raises AMPK phosphorylation can be described as activating the skin cell’s energy sensor. One that lowers mTORC1 signalling can be linked to autophagy, the recycling programme cells use to clear worn-out components. These statements belong in an ingredient dossier and in the technical section of a brand’s claim support file.

Combining signalling with metabolic read-outs

A sensor result is stronger when the energy outcome is measured in the same model. AMPK activation is commonly followed by cellular ATP measurement and by NAD+/NADH balance testing, since NAD+ availability and AMPK signalling are closely connected in cellular energy regulation.

Scoping the study

Decide which arm matters for your claim before you request a quote. An AMPK-only panel needs fewer antibodies and samples. A full AMPK/mTOR study with an autophagy marker such as LC3-II conversion gives a wider mechanism picture. Tell the laboratory the solvent, the formulation concentration and whether you want a nutrient-restricted condition in the design.

Exploration

More in Skin-Cell Energy & Metabolism Studies

Skin-Cell Energy & Metabolism Studies measure ATP, oxygen consumption, glucose use and NAD+ balance in skin cells to profile energising cosmetic actives.

Or continue with email

What does “Verified” mean?

Verified means the claimant’s company affiliation was checked.

Something not right?

Let us know if any information on this page is incorrect or if you have concerns about who manages it.